Navigation Links
Live Press Briefing on Findings of Biomedical Industry CEO Survey
Date:1/9/2012

SAN FRANCISCO, Jan. 9, 2012 EVENT:Live Press Briefing on Findings of Biomedical Industry CEO SurveyWHEN:Tuesday, Jan. 10, 2012 TIME:10 a.m. – 10:45 a.m. PT presentation and Q&A 

 WHO:-- CEOs from three biotechnology companies: NuVasive (NASDAQ: NUVA), Omniox and Theravance (NASDAQ: THRX) 

-- Executives from BayBio, California Healthcare Institute and PwC USWHERE:Grand Hyatt San Francisco 

Conference Theatre 

345 Stockton St. 

San Francisco, CA 94108  

To listen by phone in the United States: (800) 230-1951 (Logo: http://photos.prnewswire.com/prnh/20100917/NY66894LOGO )

Findings of a new survey of biomedical company CEOs about the future of the biomedical industry will be unveiled at a live press briefing hosted by the California Healthcare Institute, BayBio and PwC in San Francisco on Tuesday, Jan. 10. Some of the questions that will be addressed during the briefing include:

  • What are the biggest threats to future growth of the biomedical industry?
  • How are biomedical companies adapting to new threats and opportunities?
  • Where are biomedical companies turning for capital, and who will finance new innovation in the future?
  • How does the relationship between industry and FDA help or hinder innovation?
  • What are the key state and federal policy issues that will influence the ability for the United States and California to maintain global leadership in biomedical innovation?
  • While the biomedical industry may be poised for explosive growth over the next five to 10 years, the pace will be determined by a confluence of factors — the political, economic and regulatory environment, the availability of capital, health reform, globalization and state and federal budget deficits. These factors and the relative risks and opportunities they represent to the biomedical industry are among the topics explored by the survey.

    The briefing will include a presentation of research highlights, followed by a candid discussion among the CEOs of three California-based biomedical companies. The briefing will allow time at the conclusion for questions from the audience and members of the media.

  • NuVasive, Alexis Lukianov, Chairman and CEO
  • Omniox, Stephen Cary, Ph.D., CEO and Co-Founder
  • Theravance, Rick Winningham, Chairman and CEO
  • BayBio, Gail Maderis, President and CEO
  • California Healthcare Institute, David Gollaher, Ph.D., President and CEO
  • PwC, Tracy Lefteroff, National Life Sciences Partner
  • About the California Healthcare Institute
    CHI represents more than 275 leading biotechnology, medical device, diagnostics, and pharmaceutical companies, and public and private academic biomedical research organizations. CHI's mission is to advance responsible public policies that foster medical innovation and promote scientific discovery. CHI's website is www.chi.org. Follow us on Twitter @calhealthcare, Facebook, LinkedIn and YouTube.

    About BayBio
    BayBio is Northern California's life science association, supporting the regional bioscience community through advocacy, enterprise support, and the enhancement of research collaboration. Its members include organizations engaged in, or supportive of, research, development and commercialization of life science technologies. Online at www.baybio.org.Follow BayBio on Twitter at @baybio

    About the PwC Network
    PwC firms help organizations and individuals create the value they're looking for. We're a network of firms in 158 countries with close to 169,000 people who are committed to delivering quality in assurance, tax and advisory services. Tell us what matters to you and find out more by visiting us at www.pwc.com.
    © 2011 PricewaterhouseCoopers LLP, a Delaware limited liability partnership. All rights reserved. PwC refers to the US member firm, and may sometimes refer to the PwC network. Each member firm is a separate legal entity. Please see www.pwc.com/structure for further details.

     

     

     


    '/>"/>
    SOURCE PwC
    Copyright©2010 PR Newswire.
    All rights reserved

    Related biology technology :

    1. Veracyte Announces Medicare Coverage for Its Afirma® Gene Expression Classifier for Improved Thyroid Nodule Diagnosis
    2. Generex Subsidiary Antigen Express Provides Update on AE37 Cancer Vaccines Clinical & Regulatory Strategy
    3. Breast Cancer Vaccine Being Developed by Generex Subsidiary Antigen Express to be Featured on Bloomberg Television Today
    4. Compressus Drives Programmable Workflow And Unprecedented Flexibility With Introduction of MEDxConnect™ v4.0
    5. Nations Best Health Care Organizations for Patient Satisfaction, Core Measures Honored by Press Ganey
    6. Bright Light into the Ear Canal Treats Seasonal Depression Effectively in Two Clinical Trials Presented by Valkee and University of Oulu
    7. Epitomics, Inc. Receives Notice of Allowance from the United States Patent and Trademark Office for a Novel Method for Identifying Differentially Expressed Proteins
    8. Drug-Free BLOOD PRESSURE Control & Medical "Take-Away" Treatment are Potential Win-Win Solutions in Health Care
    9. Optics Express Focus Issue: Collective phenomena in photonic, plasmonic and hybrid structures
    10. ReportsnReports: Depression Therapeutics Market to Reach $10.9 Billion by 2018
    11. Nexcelom Bioscience to Distribute FCS Express 4 Cytometry Software with Cellometer Vision CBA Instruments
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:7/31/2020)... ... , ... eSource has long been touted as the solution to high data ... the reasons it did not take off as quickly as people initially expected, and ... moving towards capturing data electronically for clinical trials and then repurposing it for downstream ...
    (Date:7/18/2020)... ... July 16, 2020 , ... “We are thrilled to ... Bioactives. “It’s the only technology of its kind on the market and we were ... with the protective capacity of traditional cultured ingredients, creating a natural way to extend ...
    (Date:7/10/2020)... ... July 09, 2020 , ... In most research ... to suppress pigment formation in zebrafish embryos, maintaining optical transparency to facilitate microscopic ... MA has been using the zebrafish model to investigate the causes of leukaemia ...
    (Date:7/1/2020)... (PRWEB) , ... June 29, 2020 , ... ... access to competitively procured purchasing contracts to its membership, recently named BioFit ... TIPS members with the opportunity to purchase ergonomic seating, cafeteria tables, book trucks ...
    Breaking Biology Technology:
    (Date:7/1/2020)... ... 2020 , ... Cure Glioblastoma, a registered 501(c)(3) nonprofit research ... adult brain cancer—announced today the appointments of its first Senior Fellows: John Boockvar, ... organization’s initiatives and overall vision. , "Senior Fellows are more than advisors; they ...
    (Date:6/28/2020)... ... June 25, 2020 , ... In an upcoming episode scheduled ... accelerated Point of Care Testing solutions (POCT). Check local listings for more info. , ... medical offices and are shipped to labs throughout the country. Results are then available ...
    (Date:6/23/2020)... Md. (PRWEB) , ... June ... ... leading provider of gene-to-protein and monoclonal antibody development services, today announced that ... protein-based products and services to the pharmaceutical, diagnostics, and research industries. The ...
    Breaking Biology News(10 mins):